Nevertheless, ongoing clinical trials are exploring novel treatment approaches for BRAF-mutated colorectal cancer, including combinations of targeted therapies, immunotherapies, and chemotherapy [311]. The gene discussed is BRAF; the disease is colorectal cancer.